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The long-term clinical success of coronary artery bypass grafting with 
autologous aphenous vein is limited by progressive medial and neointimal 
thickening in the graft and superimposed atherosclerosis. We sought to 
reduce wall thickening by applying an external stent to experimental grafts 
in pigs. The diameter of the stent was designed to allow unrestricted initial 
expansion of the vein in response to arterial pressure and the stent material 
was highly porous so as to minimize advential disruption. Four weeks after 
graft implantation, stented grafts had a larger lumen (11.2 _ 6.2 [standard 
deviation[ mm z versus 7.6 -- 3.4 mm 2, p < 0.05, n = 9) and an almost 
fourfold thinner media (0.14 _+ 0.08 versus 0.49 +- 0.22, p < 0.001) and 
neointima (0.10 -+ 0.07 versus 0.35 - 0.24, p < 0.001) than paired 
unstented grafts in the same animals. Cell proliferation was also greatly 
reduced by stenting in the neointimal and medial layers. The stenting 
procedure devised here is readily applicable to clinical coronary bypass 
grafts. (J Thorac Cardiovasc Surg 1996;112:79-84) 
B ypass of stenotic coronary arteries with autolo- gous saphenous vein has become an established 
treatment for end-stage atherosclerotic disease, with 
more than 400,000 procedures done in the United 
States alone each year. a The long-term clinical 
success of coronary bypass grafting, however, is 
limited by occlusion of up to 50% of grafts within 10 
years. 2"4 Late occlusion results from progressive 
medial and neointimal thickening with superim- 
posed vein graft atherosclerosis. Apart from therapy 
to lower lipid levels, 5 no pharmacologic or surgical 
intervention has been shown conclusively to influ- 
ence the evolution of these changes either in man or 
in experimental models. 
Recent work has established that migration and 
proliferation of vascular smooth muscle cells in 
response to endogenously generated growth factors 
underlies graft wall thickening. 6-8 Growth factor 
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production may be stimulated by increased wall 
stress; 9 hence placement of a restrictive external 
stent around vein grafts reduces total wall thicken- 
ing.10, 11 This, however, also promotes neointima 
formation leading to an overall reduction in luminal 
size,10, ~1 possibly as a result of disruption of the vasa 
vasorum and resulting hypoxia. 12 
We investigated here the effect of a highly porous, 
nonrestrictive xternal polyester stent (Fig. 1) on 
luminal size and on the degree of medial and intimal 
thickening and cell proliferation in a pig saphenous 
vein graft model. ~3 Four weeks after implantation, 
we found that stented grafts had a larger lumen and 
dramatically reduced wall thickening compared with 
unstented grafts. 
Material and methods 
Studies were done with "white race" pigs (n = 9, weight 
25 to 30 kg), which received humane care according to the 
Home Office Animals (Scientific Procedures) Act 1986 
(HMSO 1990). Animals were subjected to premedication, 
anesthesia, nd autologous saphenous vein into common 
carotid artery bypass grafting by a modification of the 
method described previously. 14 In brief, segments of 
saphenous vein were dissected, rinsed in iso-osmotic 
sodium chloride solution (0.9 gm" L -1) containing 2 
IU/ml heparin and 50/xg/ml glyceryl trinitrate, and stored 
in the same solution at room temperature (23 ° C) until 
needed. Both common carotid arteries of the pigs were 
exposed. A 3 cm segment of one artery at a time was 
removed and replaced with a segment of saphenous vein 
cut to allow implantation without longitudinal stretching. 
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Fig. 1. Vascutek graft stent. 
Anastomoses were conducted end-to-end with reversed 
vein, beveled at 45 degrees, with continuous 7-0 Prolene 
polypropylene sutures (Ethicon, Inc., Somerville, N.J.). TM 
Proximal anastomoses were always done first; in the case 
of stented grafts the vein segments were passed through 
the stent before the distal anastomosis was completed. 
The stent (Fig. 1) comprised a continuous 6 mm 
diameter VP1200 polyester locknit tube externally sup- 
ported with helically wound 0.8 mm polypropytene (gift of 
Vascutek Ltd, Inchinnan, Renfrewshire, United King- 
dom). The stent was cut o a slightly greater length than 
the graft and held in position by two single 7-0 Prolene 
polypropylene stitches placed in the adventitia of the 
artery at each end. Each animal received a stented graft 
on one side and a control (unstented) graft on the 
opposite side. The entire procedure took 50 minutes with 
the order of implantation of stented and unstented grafts 
randomized among pigs. The use of the distal or proximal 
portions of the veins for stented or unstented grafts was 
also randomized. 
The animals were allowed to recover and fed a normal 
chow diet for 4 weeks. Grafts were then removed, pres- 
sure fixed ex vivo at 100 mm Hg for 10 minutes with the 
use of 10% buffered formal saline solution, post-fixed in 
the same solution for approximately 24 hours, and then 
processed for wax embedding. Transverse (5/xm) sections 
were cut at four levels approximately 0.75 mm apart, 
mounted on glass slides, tained with alcian blue Miller's 
elastic van Gieson stain, and examined under a light 
microscope. Vessel wall dimensions were measured by 
computer-aided planimentry (MicroScale TM/TC image 
analysis system, Digithurst Ltd, Royston, Herts, United 
Kingdom), as described previously. 13In brief, luminal, 
intimal, and medial perimeters and areas were computed 
with use of the luminal boundary and internal and exter- 
nal elastic laminae as delimiters, and mean values were 
then calculated for all sections from the same graft. 
Average intimal, medial, and vessel wall thicknesses were 
derived from the area and perimeter data. 13 
Furthermore, proliferating cell nuclear antigen was 
detected in the sections by immunocytochemistry as de- 
scribed previously. 15 Briefly, we used a primary monoclo- 
hal antibody (PC10, Dako Ltd, High Wycombe, Bucks, 
United Kingdom) at a 1/100 dilution. This was followed by 
a 1/50 dilution of biotinylated anti-mouse immunoglobulin 
G (Dako) and avidin-biotin-peroxidase conjugate (D ko) 
according to the manufacturer's instructions. Sections 
were counterstained with Harris' hematoxylin stain. Total 
number of cells and number of strongly positive cells were 
counted in both intima and media in five microscopic 
fields per section with a ×40 objective. 
Statistical analysis. Values are shown as the mean plus 
or minus the standard deviation (SD). Significance be- 
tween groups was established with the Mann-Whitney U
test, and data were considered significant if the p value 
was equal to or less than 0.05. 
Results 
The luminal diameter of pig saphenous vein mea- 
sured by ultrasonography in situ before implantation 
was 1.6 _+ 0.3 mm (SD, n = 9). Immediately after 
grafting to the common carotid artery, unstented 
veins increased in diameter to 3.6 _+ 0.6 ram. 
Placement of a 6 mm diameter porous polyester 
stent (Fig. 1) around grafts to the contralateral 
artery had no effect on the diameter of the grafts 
(also 3.6 _+ 0.6 mm) as measured by ultrasonogra- 
phy. 
All grafts, whether stented or not, were patent 4 
weeks after implantation. As illustrated in Fig. 2 and 
summarized in Table I, stented and unstented grafts 
had a similar total (lumen plus wall) cross-sectional 
area that was approximately four times greater than 
that of the original vein. This confirmed that the 
stent allowed expansion of the graft in response to 
arterial pressure. Unstented grafts showed an in- 
crease in luminal area compared with that of un- 
grafted vein. Unstented grafts also showed medial 
enlargement, fragmentation of the internal elastic 
lamina, and development of a neointima (Fig. 2, 
Table I), in agreement with previous observationsJ 3 
Stented grafts had a significantly greater final lumi- 
nal area than unstented grafts (Table I). There was 
no medial enlargement compared with ungrafted 
vein, and neointima formation was dramatically 
reduced almost fourfold compared with that in 
unstented grafts (Fig. 2, Table I). As a result, the 
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Fig. 2. Histologic appearance of ungrafted saphenous vein (a), representative stented graft (b) (s ent 
material removed before wax mbedding), and representative unstented graft (e). Small arrows indicate 
position of internal elastic lamina and large arrows indicate external elastic lamina. Scale bar relates to all 
panels and represents 0.5 ram. 
encroachment of the intima into the lumen was 
reduced by stenting from 33% to 13% (Fig. 2, Table 
I). 
The presence of cells progressing through the c ll 
cycle was detected by immunocytochemistry for 
proliferating cell nuclear antigen (PCNA)J 5'16 
PCNA-positive cells were rarely detected in un- 
grafted vein but were abundant inthe media and the 
most luminal aspect of the neointima of unstented 
grafts (Fig. 3). For quantification fPCNA labeling, 
the total number and the number of PCNA-positive 
cells were counted in both the intima and the media 
in five microscopic fields of view with a Leica 
Laborlux S microscope (Leica Instruments GmbH, 
Nussloch, Germany) and ×40 objective. The num- 
ber of PCNA-positive cells was expressed as a 
proportion of the total cell number (PCNA index). 
The medial PCNA index was reduced by stenting 
from 21% _+ 4% to 2.4% _+ 2.2% (p < 0.001). The 
neointimal PCNA index was also reduced by stent- 
ing from 24% ___ 4% to 7% -+ 3% (p < 0.01). PCNA 
labeling in the neoadventitia was observed in both 
stented and unstented grafts (Fig. 3). The presence 
of microvessels penetrating the media of stented 
grafts can also be noted in Fig. 3. There were 
endothelial cells lining these vessels, as confirmed by 
staining for Dolichos bifloros lectin (results not 
shown). Such vessels were absent from the media of 
ungrafted vein or unstented grafts (Fig. 3). 
Discussion 
Morphologic and clinical studies of human vein 
grafts (reviewed in references 17 through 20) dem- 
onstrate three phases in the response of vein to 
arterial implantation. In the first hours to days, 
mural or occlusive thrombosis can occur as a result 
of endothelial denudation and rheologic distur- 
bance. Over the next months, there is progressive 
medial and neointimal thickening as a result of the 
migration and proliferation of vascular smooth mus- 
cle cells. In extreme cases, this can compromise flow 
directly or promote thrombotic occlusion. During 
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Fig. 3. Immunocytochemistry for PCNA in ungrafted vein (a), representative stented graft (b) (note 
presence of vasa vasorum indicated by large arrows), and representative unstented graft (c) (note presence 
of PCNA-positive cells in neointima close to luminal surface indicated by small arrows). Small tn'angles 
indicate position of internal elastic lamina and large triangles indicate xternal elastic lamina. Scale bar 
relates to all panels and represents 0.5 ram. 
Table I. Dimensions of saphenous vein and unstented and stented grafts 
Parameter Ungrafled vein Unstented graft Stented graft p Value 
Total cross-sectional rea (mm 2) 3.7 -- 1.2 18.0 _+ 5.8 13.9 _+ 5.9 0.1 
Luminal area (mm 2) 2.5 _+ 1.2 7.6 + 3.4 11.2 + 6.2 <0.05 
Medial area (ram 2) 1.2 _+ 0.9 6.55 + 2.62 1.62 + 0.52 <0.001 
Intimal area (mm 2) 0 3.84 _+ 3.3 1.06 _+ 0.37 <0.001 
Intimal encroachment (%) 0 33.2 _+ 19.1 13.3 _+ 13.4 <0.005 
Total wall thickness (mm) 0.13 -+ 0.06 0.85 _+ 0.38 0.25 _+ 0.14 <0.001 
Medial thickness (mm) 0.13 -+ 0.06 0.49 _+ 0.22 0.14 _+ 0.08 <0.001 
Intimal thickness (mm) 0 0.35 -+ 0.24 0.10 _+ 0.07 <0.001 
Results for stented versus uustented grafts were compared by Mann-Whitney U test. Values are expressed as mean plus or minus standard eviation. 
the following years, there is a tendency for atheroma 
to occur superimposed on the thickened intima and 
this is associated with an increasing rate of graft 
occlusion between 5 and 10 years after implanta- 
tion. 2-4 Experimental grafts in dogs, rabbits, nonhu- 
man primates, and pigs 14'21-24 have reproduced 
many aspects of the human pathologic process. 
Progressive medial and neointimal thickening oc- 
curs and hypercholesterolemia promotes deposition 
of lipoproteins in the grafts. 23 
Early thrombotic occlusions can be reduced in 
both clinical and experimental studies by a variety of 
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antiplatelet agents 25 and also by avoidance of inci- 
dental vessel wall injury during surgical preparation 
and implantation. 14' 26 Both platelet activation and 
tissue injury have also been implicated in the patho- 
genesis of neointimal thickening. 19'2°'2%3° How- 
ever, neither antiplatelet therapy nor avoidance of 
surgical preparative injury has been shown conclu- 
sively to eliminate medial and neointimal thickening 
either in experimental models or in human vein 
grafts. 26 It has recently been shown that grafting 
stimulates the production of endogenous growth 
factors from pig saphenous vein, s which may explain 
the platelet-independence of wall thickening. Vessel 
wall thickening may then be regarded as an intrinsic 
adaptation of the vein to arterial pressure. Indeed, 
Zwolak, Adams, and Clowes 9 noted that the ratio of 
luminal radius to wall thickness in grafts tends to 
adapt to the same value as that in the grafted artery, 
which suggests that wall thickening occurs to nor- 
malize tangential wall stress. This hypothesis is 
partly borne out by two studies that showed that 
restrictive xternal stents reduce overall graft wall 
thickening. 1°'11 However, although such stenting 
reduces medial thickening, it promotes neointimal 
thickening and leads to a reduction rather than an 
increase in final luminal size. Enhanced neointima 
formation in such stented grafts may result from 
reduction of fluid flux, thereby increasing the effec- 
tive concentration of endogenously produced mito- 
gens. Another possibility is that adventitia disrup- 
tion leads to vessel wall hypoxia. 12' 31 Hence ligating 
the femoral artery vasa vasorum in the pig femoral 
artery or placing a silicone-rubber collar around the 
rabbit carotid artery causes arapid neointimal thick- 
ening that can be avoided if adventitial regrowth is 
encouraged.12' 3~ 
In this study, a highly porous material was used so 
as to minimize any effects on fluid flux and permit 
the unhindered growth of a new adventitia. The size 
of the stent was chosen to allow unrestricted expan- 
sion of the graft in initial response to arterial 
pressure. The stent then became incorporated into 
the neoadventitia whereupon it presumably began 
to bear a proportion of the wall stress. Reduction in 
the tangential wall stress borne by the graft might 
then explain why medial thickening was abolished 
and neointimal formation was dramatically reduced, 
leading to an increase in final luminal size. Another 
possibility, supported by the observation of vasa 
vasorum penetrating the media of stented grafts, is 
that modification of the structure of the neoadven- 
titia led to improved fluid flux or less hypoxia. The 
PCNA data imply that reduction in the rate of 
smooth muscle cell proliferation contributed sub- 
stantially to the reduction in wall thickening. 
The type of stenting material and the procedure 
used here are readily applicable to human saphenous 
vein grafts. An increase in final luminal size in stented 
grafts would be expected to favor unrestricted flow and 
hence reduce thrombotic occlusions. Decreased wall 
thickness also implies a reduced risk of lipoprotein and 
macrophage accumulation and hence less vein graft 
atheroma. The impact of this kind of stent on wall 
thickness and patency needs now to be tested irectly 
in clinical studies. 
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